French drugmaker Sanofi has made a $40 million investment in Gyroscope Therapeutics, with another $20 million potentially on offer as the UK biotech advances its clinical-stage gene therapies for ...

Abstract: Rate bias technology, as another way to solve the lock-in threshold problem, eliminates the extra random walk noise resulting from frequent dead-zone crossing of dithered-bias laser ...